Immunosuppressant agents in the treatment of glomerulonephritis. 1. Corticosteroid drugs.
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001623:Betamethasone / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D003907:Dexamethasone / Q000627:therapeutic use; D004351:Drug Resistance; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011507:Proteinuria / Q000188:drug therapy; D013924:Thrombophlebitis / Q000139:chemically induced; D013927:Thrombosis / Q000139:chemically induced; D014221:Triamcinolone / Q000627:therapeutic use
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014221:Triamcinolone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D001623:Betamethasone; D011239:Prednisolone; D011241:Prednisone